🇺🇸 FDA
Patent

US 10934360

Human monoclonal antibodies against EPHA4 and their use

granted A61KA61K2039/505A61K39/39558

Quick answer

US patent 10934360 (Human monoclonal antibodies against EPHA4 and their use) held by The Government of the United States of America as represented by the Secretary of the Deptartment of Health and Human Services expires Mon Feb 25 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Government of the United States of America as represented by the Secretary of the Deptartment of Health and Human Services
Grant date
Tue Mar 02 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Feb 25 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
12
CPC classes
A61K, A61K2039/505, A61K39/39558, A61P, A61P25/28